Mortality from colorectal cancer is reduced through screening and early detection; moreover,
removal of neoplastic lesions can reduce cancer incidence. While understanding of the risk …

Background: Performance characteristics of fecal immunochemical tests (FITs) to screen for
colorectal cancer (CRC) have been inconsistent. Purpose: To synthesize data about the …

The use of the fecal occult blood test (FOBT) for colorectal cancer (CRC) screening is
supported by randomized trials demonstrating effectiveness in cancer prevention and widely …

Objective Since the publication of the first Asia Pacific Consensus on Colorectal Cancer
(CRC) in 2008, there are substantial advancements in the science and experience of …

Background: Studies report inconsistent performance of fecal immunochemical tests (FITs)
for colorectal cancer (CRC) and advanced adenomas. Purpose: To summarize performance …

Introduction: Colorectal cancer (CRC) is the third most common cancer in males and second
in females, and the fourth most common cause of cancer death worldwide. Currently, about …

There is a wide choice of fecal occult blood tests (FOBTs) for colorectal cancer screening.
Goal: To highlight the issues applicable when choosing a FOBT, in particular which FOBT is …

Colorectal cancer (CRC) is one of the most common malignancies that is usually detected
late in the clinic. The currently available diagnostic tools for CRC are either invasive or …

Background & Aims The serrated pathway is a distinct pathway of colorectal carcinogenesis
that has been implicated in development of a substantial proportion of interval colorectal …

Colorectal cancer (CRC) has become the third most common cancer in the world. Screening
has been shown to be an effective way to identify early CRC and precancerous lesions, and …